Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced
Expansion and fortification of relationship since 2020 with established pharmaceutical company in Chile
Supply of Avicanna’s active pharmaceutical ingredients for existing commercial and pipeline of pharmaceutical